Back to Results
First PageMeta Content
CSL Limited / Pharmacology / Canada Steamship Lines / Gardasil / Behring / Food and Drug Administration / Forward-looking statement / Compound annual growth rate / Pharmaceutical sciences / CSL Behring / Clinical research


CSL Limited 2012 Full Year Result 22 August 2012 Disclaimer Forward looking statements
Add to Reading List

Document Date: 2012-08-21 18:41:23

Open Document

File Size: 516,15 KB

Share Result on Facebook

Company

Merck & Co. Inc. / Australian Securities Exchange / CSL Limited / Australia / Canada & USA Capital Management / /

Continent

Asia / North America / Europe / /

Country

Australia / United States / /

Currency

AUD / USD / cent / /

Event

Security Buyback / M&A / FDA Phase / Dividend Issuance / /

Facility

Broadmeadows facility / Pro-thrombin complex / /

IndustryTerm

plasma products / manufacturing / past and current capital management / healthcare regulations / /

MedicalCondition

subcutaneous CIDP / Recombinant haemophilia / influenza / CIDP / /

MedicalTreatment

self administration / /

Organization

FY2013 Board / European Union / US Food and Drug Administration / /

Product

RiaSTAP™ / CIDP / /

SocialTag